• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有相同载脂蛋白(a)异构体的个体之间脂蛋白(a)浓度的差异由脂蛋白(a)的产生速率决定。

Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production.

作者信息

Rader D J, Cain W, Zech L A, Usher D, Brewer H B

机构信息

Molecular Disease Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892.

出版信息

J Clin Invest. 1993 Feb;91(2):443-7. doi: 10.1172/JCI116221.

DOI:10.1172/JCI116221
PMID:8432853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC287951/
Abstract

Lipoprotein(a) [Lp(a)] is an atherogenic lipoprotein which is similar in structure to, but metabolically distinct from, LDL. Factors regulating plasma concentrations of Lp(a) are poorly understood. Apo(a), the protein that distinguishes Lp(a) from LDL, is highly polymorphic, and apo(a) size is inversely correlated with plasma Lp(a) level. Even within the same apo(a) isoform class, however, plasma Lp(a) concentrations vary widely. A series of in vivo kinetic studies were performed using purified radiolabeled Lp(a) in individuals with the same apo(a) isoform but different Lp(a) levels. In a group of seven subjects with a single S4-apo(a) isoform and Lp(a) levels ranging from 1 to 13.2 mg/dl, the fractional catabolic rate (FCR) of 131I-labeled S2-Lp(a) (mean 0.328 day-1) was not correlated with the plasma Lp(a) level (r = -0.346, P = 0.45). In two S4-apo(a) subjects with a 10-fold difference in Lp(a) level, the FCR's of 125I-labeled S4-Lp(a) were very similar in both subjects and not substantially different from the FCRs of 131I-S2-Lp(a) in the same subjects. In four subjects with a single S2-apo(a) isoform and Lp(a) levels ranging from 9.4 to 91 mg/dl, Lp(a) concentration was highly correlated with Lp(a) production rate (r = 0.993, P = 0.007), but poorly correlated with Lp(a) FCR (mean 0.304 day-1). Analysis of Lp(a) kinetic parameters in all 11 subjects revealed no significant correlation of Lp(a) level with Lp(a) FCR (r = -0.53, P = 0.09) and a strong correlation with Lp(a) production rate (r = 0.99, P < 0.0001). We conclude that the substantial variation in Lp(a) levels among individuals with the same apo(a) phenotype is caused primarily by differences in Lp(a) production rate.

摘要

脂蛋白(a)[Lp(a)]是一种致动脉粥样硬化脂蛋白,其结构与低密度脂蛋白(LDL)相似,但代谢方式不同。目前对调节Lp(a)血浆浓度的因素了解甚少。载脂蛋白(a)[Apo(a)]是使Lp(a)区别于LDL的蛋白质,具有高度多态性,且Apo(a)大小与血浆Lp(a)水平呈负相关。然而,即使在相同的Apo(a)异构体类别中,血浆Lp(a)浓度也有很大差异。我们使用纯化的放射性标记Lp(a)对具有相同Apo(a)异构体但Lp(a)水平不同的个体进行了一系列体内动力学研究。在一组7名具有单一S4 - Apo(a)异构体且Lp(a)水平在1至13.2mg/dl之间的受试者中,131I标记的S2 - Lp(a)的分解代谢率(FCR)(平均0.328天-1)与血浆Lp(a)水平无关(r = -0.346,P = 0.45)。在两名Lp(a)水平相差10倍的S4 - Apo(a)受试者中,125I标记的S4 - Lp(a)的FCR在两名受试者中非常相似,且与同一受试者中131I - S2 - Lp(a)的FCR没有实质性差异。在4名具有单一S2 - Apo(a)异构体且Lp(a)水平在9.4至91mg/dl之间的受试者中,Lp(a)浓度与Lp(a)生成率高度相关(r = 0.993,P = 0.007),但与Lp(a)FCR相关性较差(平均0.304天-1)。对所有11名受试者的Lp(a)动力学参数分析显示,Lp(a)水平与Lp(a)FCR无显著相关性(r = -0.53,P = 0.09),而与Lp(a)生成率有很强的相关性(r = 0.99,P < 0.0001)。我们得出结论,具有相同Apo(a)表型的个体之间Lp(a)水平的显著差异主要是由Lp(a)生成率的差异引起的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a882/287951/3201423b46e5/jcinvest00037-0076-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a882/287951/27dc50f9662e/jcinvest00037-0076-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a882/287951/3201423b46e5/jcinvest00037-0076-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a882/287951/27dc50f9662e/jcinvest00037-0076-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a882/287951/3201423b46e5/jcinvest00037-0076-b.jpg

相似文献

1
Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production.具有相同载脂蛋白(a)异构体的个体之间脂蛋白(a)浓度的差异由脂蛋白(a)的产生速率决定。
J Clin Invest. 1993 Feb;91(2):443-7. doi: 10.1172/JCI116221.
2
The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate.血浆脂蛋白(a)浓度与载脂蛋白(a)异构体大小的负相关并非由于脂蛋白(a)分解代谢的差异,而是由于生成速率的差异。
J Clin Invest. 1994 Jun;93(6):2758-63. doi: 10.1172/JCI117292.
3
Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.肾病综合征患者的脂蛋白(a):免疫抑制和蛋白尿的影响
Miner Electrolyte Metab. 1996;22(1-3):26-30.
4
Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).终末期肾病患者血浆中脂蛋白(a)浓度升高与载脂蛋白(a)的大小多态性无关。
J Clin Invest. 1993 Feb;91(2):397-401. doi: 10.1172/JCI116213.
5
Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of the apoA-IV-2 isoprotein.人载脂蛋白A-IV-1在体内的快速转运和分解代谢以及载脂蛋白A-IV-2同工蛋白较慢的分解代谢。
J Clin Invest. 1993 Aug;92(2):1009-17. doi: 10.1172/JCI116606.
6
[Relation of pentanucleotide repeat polymorphism of apolipoprotein (a) gene to plasma lipoprotein (a) level among Chinese patients with myocardial infarction and cerebral infarction].[载脂蛋白(a)基因五核苷酸重复序列多态性与中国心肌梗死和脑梗死患者血浆脂蛋白(a)水平的关系]
Zhonghua Yi Xue Za Zhi. 2002 Oct 25;82(20):1396-400.
7
[Relationship between lipoprotein A, apolipoprotein A and their isoforms in parents and children].[脂蛋白A、载脂蛋白A及其亚型在父母与子女中的关系]
An Esp Pediatr. 1998 Jun;48(6):587-92.
8
Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles.脂蛋白(a)浓度的变化与不同的载脂蛋白(a)等位基因相关。
J Clin Invest. 1994 Apr;93(4):1481-92. doi: 10.1172/JCI117126.
9
The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings.人类血浆脂蛋白(a)中载脂蛋白(a)和B-100的代谢
Metabolism. 2005 Mar;54(3):361-9. doi: 10.1016/j.metabol.2004.10.001.
10
Apolipoprotein(a) isoform-specific changes of lipoprotein(a) after kidney transplantation.肾移植后脂蛋白(a)的载脂蛋白(a)异构体特异性变化
Eur J Hum Genet. 2003 Sep;11(9):693-9. doi: 10.1038/sj.ejhg.5201016.

引用本文的文献

1
Variation in lipoprotein(a) response to potent lipid lowering: The role of apolipoprotein (a) isoform size.脂蛋白(a)对强效降脂反应的差异:载脂蛋白(a)异构体大小的作用。
J Clin Lipidol. 2025 Jan-Feb;19(1):39-50. doi: 10.1016/j.jacl.2024.11.008. Epub 2024 Dec 4.
2
Lipoprotein(a) and cardiovascular disease.脂蛋白(a)与心血管疾病。
Biochem J. 2024 Oct 2;481(19):1277-1296. doi: 10.1042/BCJ20240037.
3
Impact of anti-oestrogen therapy on lipoprotein(a) in postmenopausal women: a systematic review and meta-analysis of double-blind placebo-controlled clinical studies.

本文引用的文献

1
Turnover of lipoprotein (a) in man.人体内脂蛋白(a)的周转
J Clin Invest. 1980 Jun;65(6):1483-90. doi: 10.1172/JCI109813.
2
Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins.人血浆脂蛋白(a)的异质性。脂蛋白亚类及其载脂蛋白的分离与鉴定。
J Biol Chem. 1984 Sep 25;259(18):11470-8.
3
Molecular weight determination of protein-dodecyl sulfate complexes by gel electrophoresis in a discontinuous buffer system.在不连续缓冲系统中通过凝胶电泳测定蛋白质 - 十二烷基硫酸盐复合物的分子量
抗雌激素疗法对绝经后女性脂蛋白(a)的影响:双盲安慰剂对照临床研究的系统评价和荟萃分析
Endocrine. 2023 May;80(2):292-302. doi: 10.1007/s12020-022-03287-2. Epub 2022 Dec 21.
4
Sortilin enhances secretion of apolipoprotein(a) through effects on apolipoprotein B secretion and promotes uptake of lipoprotein(a).Sortilin 通过影响载脂蛋白 B 的分泌而增强载脂蛋白(a)的分泌,并促进脂蛋白(a)的摄取。
J Lipid Res. 2022 Jun;63(6):100216. doi: 10.1016/j.jlr.2022.100216. Epub 2022 Apr 22.
5
Lipoprotein(a) and Metabolic Syndrome.脂蛋白(a)与代谢综合征。
Dtsch Arztebl Int. 2022 Apr 15;119(15):270-276. doi: 10.3238/arztebl.m2022.0153.
6
Lipoprotein(a) as an Old and New Causal Risk Factor of Atherosclerotic Cardiovascular Disease.脂蛋白(a)作为动脉粥样硬化性心血管疾病的一个古老和新的因果风险因素。
J Atheroscler Thromb. 2019 Jul 1;26(7):583-591. doi: 10.5551/jat.RV17034. Epub 2019 Apr 30.
7
Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol-Lowering Therapy.脂蛋白(a)颗粒生成作为不同载脂蛋白(a)亚型大小和背景降脂治疗时血浆脂蛋白(a)浓度的决定因素。
J Am Heart Assoc. 2019 Apr 2;8(7):e011781. doi: 10.1161/JAHA.118.011781.
8
CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects.使用阿那曲匹抑制胆固醇酯转运蛋白(CETP)可降低轻度高胆固醇血症患者脂蛋白(a)的生成。
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1770-1775. doi: 10.1161/ATVBAHA.117.309549. Epub 2017 Jul 20.
9
The metabolism of lipoprotein (a): an ever-evolving story.脂蛋白(a)的代谢:一个不断发展的故事。
J Lipid Res. 2017 Sep;58(9):1756-1764. doi: 10.1194/jlr.R077693. Epub 2017 Jul 18.
10
A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms.一项针对经载脂蛋白(a)异构体校正的脂蛋白(a)浓度的全基因组关联荟萃分析。
J Lipid Res. 2017 Sep;58(9):1834-1844. doi: 10.1194/jlr.M076232. Epub 2017 May 16.
J Biol Chem. 1971 Oct 25;246(20):6328-34.
4
Abnormal low density lipoprotein metabolism in apolipoprotein E deficiency.载脂蛋白E缺乏时低密度脂蛋白代谢异常。
J Lipid Res. 1986 Mar;27(3):326-33.
5
Semi-automated enzyme-linked immunosorbent assay (ELISA) for the quantification of apolipoprotein B using monoclonal antibodies.使用单克隆抗体的半自动酶联免疫吸附测定(ELISA)法测定载脂蛋白B含量。
Clin Chim Acta. 1987 Dec;170(2-3):271-80. doi: 10.1016/0009-8981(87)90137-9.
6
Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients.血清脂蛋白(a)水平作为冠状动脉搭桥术后患者静脉移植物狭窄的预测指标。
Circulation. 1988 Jun;77(6):1238-44. doi: 10.1161/01.cir.77.6.1238.
7
Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma.Lp(a)糖蛋白表型。遗传及其与血浆中Lp(a)脂蛋白浓度的关系。
J Clin Invest. 1987 Aug;80(2):458-65. doi: 10.1172/JCI113093.
8
Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis.血液透析治疗的慢性肾衰竭患者中的脂蛋白(a)
Clin Chem. 1987 May;33(5):721.
9
The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels.血清脂蛋白(a)浓度与血管造影评估的冠状动脉粥样硬化之间的关联。对血清低密度脂蛋白水平的依赖性。
Atherosclerosis. 1986 Dec;62(3):249-57. doi: 10.1016/0021-9150(86)90099-7.
10
Lipoprotein(a) as a strong indicator for cerebrovascular disease.脂蛋白(a)作为脑血管疾病的一个重要指标。
Stroke. 1986 Sep-Oct;17(5):942-5. doi: 10.1161/01.str.17.5.942.